Role of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) in the Treatment of Retinopathy of Prematurity: A Narrative Review in the Context of Middle-Income Countries
Mangat Ram Dogra,1 Anand Vinekar2 1Grewal Eye Institute, Chandigarh, India; 2Narayana Nethralaya Eye Institute, Bangalore, IndiaCorrespondence: Anand Vinekar, Narayana Nethralaya Eye Institute, Bangalore, India, Email anandvinekar@yahoo.comAbstract: The rise in preterm births and higher survival rat...
Saved in:
Main Authors: | Dogra MR (Author), Vinekar A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
by: Yue Zhao, et al.
Published: (2018) -
Characteristics of Eyes Developing Retinal Detachment After Anti-vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity
by: Chiori Kondo, et al.
Published: (2022) -
Vascular Endothelial Growth Factor Signaling in Models of Oxygen-Induced Retinopathy: Insights Into Mechanisms of Pathology in Retinopathy of Prematurity
by: Aniket Ramshekar, et al.
Published: (2021) -
Short-term effects of intravitreal anti-vascular endothelial growth factor agents on body weight and multiple systems after treatment for retinopathy of prematurity
by: Jing Chen, et al.
Published: (2023) -
Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Inhibitors in Health and Disease
by: Sylvain Broussy
Published: (2024)